CCMN lecture series: Professor Tom Foltynie, University College London
09 February 2024, 2:00 pm–3:00 pm
Title: ‘Exenatide as a treatment for Parkinson’s disease’
This event is free.
Anna Roberts – UCL, Neuroscience, Physiology, Pharmacology
Medawar, G01Lankester Lecture TheatreGower StreetLondonWC1E 6BT
Abstract: There is great interest in the potential role of GLP-1 receptor agonists as disease modifying approaches for neurodegenerative diseases. Data from epidemiology, preclinical work in the lab as well as early clinical trial data all support a potential role for this class of agents, particularly in Parkinson’s disease. The latest data and plans going forward for Exenatide in Parkinson’s disease will be summarised in this presentation.
About the Speaker
Professor Tom Foltynie
Professor of Neurology at University College LondonMore about Professor Tom Foltynie